Elevance Health, Inc 8-K, filed Aug 4, 2021
Elevance Health, Inc. (ELV)
About this 8-K
Elevance Health, Inc filed this 8-K on August 4, 2021, reporting on events of August 3, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2021 (
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of principal executive offices) (Zip Code) |
Registrant’s telephone number, including area code:
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 3, 2021, the Board of Directors (the “Board”) of the Company elected Susan Dodson DeVore to serve as an independent director effective immediately, with a term expiring at the Company’s 2022 annual meeting of shareholders. The Board also appointed Ms. DeVore to the Audit and Finance Committees of the Board. There is no arrangement or understanding between Ms. DeVore and any other person pursuant to which she was elected to the Board, and Ms. DeVore has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended. The Board has determined that Ms. DeVore qualifies as an “audit committee financial expert” as defined in the Securities and Exchange Commission regulations.
Ms. DeVore will receive compensation for her services as a director in accordance with the Company’s standard compensation program for non-employee directors, which is filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.
A copy of the Company’s press release announcing Ms. DeVore’s election is furnished herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
Exhibit | |
| 99.1 | Press Release, dated August 3, 2021, announcing the election of Susan Dodson DeVore to the Anthem, Inc. Board of Directors. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 4, 2021
| ANTHEM, INC. | ||
| By: | /s/ Kathleen S. Kiefer | |
| Name: | Kathleen S. Kiefer | |
| Title: | Corporate Secretary | |
Exhibit 99.1
Anthem’s Board Welcomes Susan Dodson DeVore as New Director
INDIANAPOLIS – August 4, 2021 – The Board of Directors of Anthem, Inc. (NYSE: ANTM) announced that Susan Dodson DeVore has joined the Board.
Ms. DeVore’s decades of leadership in the healthcare and financial industries demonstrates her focus to create and develop solutions that promote the efficiency and sustainability of healthcare models.
Ms. DeVore recently retired after more than a decade as Chief Executive Officer and Director of Premier, Inc., which operates as a healthcare supply chain, technology and performance improvement company serving over 4,100 hospitals and health systems and 200,000 other providers of healthcare. Under her leadership, Premier had a successful initial public offering and has been publicly recognized for its ethical practices, technology innovations, quality of overall performance improvement consulting, and work environment.
Ms. DeVore also has over twenty years of finance, strategy and health care consulting experience, including as Partner and Region Leader for the Health Care Consulting Practice at Ernst & Young. She has been named multiple times to Modern Healthcare’s 100 Most Influential People and Top 25 Women in Healthcare lists. Ms. DeVore currently serves on the board of UNUM Group and previously chaired the Healthcare Leadership Council and co-chaired the National Academy of Medicine’s Value and Science Driven Health Care Collaborative.
“We are pleased to welcome Susan to our Board of Directors,” said Elizabeth Tallett, Chair, Anthem Board of Directors. “Her leadership in driving innovation through collaborations with healthcare providers and other key stakeholders will provide valuable insights to our Board as the Company continues to pursue its purpose of improving the health of humanity.”
About Anthem, Inc.
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 117 million people, including more than 44 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.
Investor Relations:
Stephen Tanal
Stephen.tanal@anthem.com
Media Relations:
Michelle Vanstory
Michelle.vanstory@anthem.com